122 related articles for article (PubMed ID: 12911518)
21. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
22. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
[TBL] [Abstract][Full Text] [Related]
23. VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
Canavese M; Dottorini T; Crisanti A
Pathog Glob Health; 2015 Sep; 109(6):255-65. PubMed ID: 26392042
[TBL] [Abstract][Full Text] [Related]
24. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.
Yañez DM; Manning DD; Cooley AJ; Weidanz WP; van der Heyde HC
J Immunol; 1996 Aug; 157(4):1620-4. PubMed ID: 8759747
[TBL] [Abstract][Full Text] [Related]
25. Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection.
Haque A; Best SE; Ammerdorffer A; Desbarrieres L; de Oca MM; Amante FH; de Labastida Rivera F; Hertzog P; Boyle GM; Hill GR; Engwerda CR
Eur J Immunol; 2011 Sep; 41(9):2688-98. PubMed ID: 21674481
[TBL] [Abstract][Full Text] [Related]
26. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
[TBL] [Abstract][Full Text] [Related]
27. Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection.
Brant F; Miranda AS; Esper L; Rodrigues DH; Kangussu LM; Bonaventura D; Soriani FM; Pinho V; Souza DG; Rachid MA; Weiss LM; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
Infect Immun; 2014 Aug; 82(8):3127-40. PubMed ID: 24818665
[TBL] [Abstract][Full Text] [Related]
28. Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection.
Huang B; Liu M; Huang S; Wu B; Guo H; Su XZ; Lu F
Parasitol Res; 2013 Jul; 112(7):2713-9. PubMed ID: 23653017
[TBL] [Abstract][Full Text] [Related]
29. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
30. Cytokine and chemokine mRNA expression in neutrophils from CBA/NSlc mice infected with Plasmodium berghei ANKA that induces experimental cerebral malaria.
Chen L; Sendo F
Parasitol Int; 2001 Jul; 50(2):139-43. PubMed ID: 11438437
[TBL] [Abstract][Full Text] [Related]
31. Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.
Randall LM; Amante FH; Zhou Y; Stanley AC; Haque A; Rivera F; Pfeffer K; Scheu S; Hill GR; Tamada K; Engwerda CR
J Immunol; 2008 Dec; 181(11):7458-62. PubMed ID: 19017933
[TBL] [Abstract][Full Text] [Related]
32. Sex-Associated Differential mRNA Expression of Cytokines and Its Regulation by Sex Steroids in Different Brain Regions in a
Legorreta-Herrera M; Nava-Castro KE; Palacios-Arreola MI; Hernández-Cervantes R; Aguilar-Castro J; Cervantes-Candelas LA; Morales-Montor J
Mediators Inflamm; 2018; 2018():5258797. PubMed ID: 30515051
[TBL] [Abstract][Full Text] [Related]
33. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
Keswani T; Bhattacharyya A
Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
[TBL] [Abstract][Full Text] [Related]
34. Loss of Toll-like receptor 7 alters cytokine production and protects against experimental cerebral malaria.
Baccarella A; Huang BW; Fontana MF; Kim CC
Malar J; 2014 Sep; 13():354. PubMed ID: 25192715
[TBL] [Abstract][Full Text] [Related]
35. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection.
Ryg-Cornejo V; Nie CQ; Bernard NJ; Lundie RJ; Evans KJ; Crabb BS; Schofield L; Hansen DS
Immunobiology; 2013 Feb; 218(2):263-71. PubMed ID: 22704523
[TBL] [Abstract][Full Text] [Related]
36. IFN-gamma suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor.
Huang Z; Xin J; Coleman J; Huang H
J Immunol; 2005 Feb; 174(3):1332-7. PubMed ID: 15661890
[TBL] [Abstract][Full Text] [Related]
37. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.
Nie CQ; Bernard NJ; Schofield L; Hansen DS
Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053
[TBL] [Abstract][Full Text] [Related]
38. Suppressor of cytokine signaling 1 is required for the differentiation of CD4+ T cells.
Catlett IM; Hedrick SM
Nat Immunol; 2005 Jul; 6(7):715-21. PubMed ID: 15924143
[TBL] [Abstract][Full Text] [Related]
39. Silencing SOCS1 in dendritic cells promote survival of mice with systemic Candida albicans infection via inducing Th1-cell differentiation.
Shi D; Li D; Wang Q; Kong X; Mei H; Shen Y; Liu W
Immunol Lett; 2018 May; 197():53-62. PubMed ID: 29581081
[TBL] [Abstract][Full Text] [Related]
40. Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease.
Bullen DV; Darwiche R; Metcalf D; Handman E; Alexander WS
Immunology; 2001 Sep; 104(1):92-8. PubMed ID: 11576226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
